Fujifilm And Kyowa Hakko Kirin Join Hunt For Avastin Biosimilar
This article was originally published in PharmAsia News
Executive Summary
The Japanese biosimilar joint venture has its eyes on EU, U.S. and Japan despite regulatory and market uncertainties.